Ardagh Group (ARD) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
25 Nov, 2025Executive summary
Completed a major recapitalization in November 2025, including a $4.3 billion debt-for-equity swap, $1.5 billion new capital, and transfer of ownership to creditors, significantly deleveraging the balance sheet and extending debt maturities to 2030.
Q3 2025 revenue was $2,504 million, up 5% year-over-year; nine-month revenue reached $7,215 million, up 4%.
Group Adjusted EBITDA for Q3 2025 was $394 million, a 9% increase year-over-year; nine-month Adjusted EBITDA was $1,072 million, up 7%.
Net loss for Q3 2025 was $326 million, compared to a $36 million loss in Q3 2024; nine-month net loss was $535 million, compared to $377 million in 2024.
Focused on deleveraging through organic EBITDA growth, cost control, and operational improvements.
Financial highlights
Adjusted EBITDA margin for Q3 2025 was 15.7%, up from 15.2% in Q3 2024.
LTM adjusted EBITDA reached $1,347 million, up $73 million year-to-date.
Cash and available liquidity at September 30, 2025, was $1.07 billion; $438 million excluding AMP.
Exceptional items of $392 million were recognized in the nine months ended September 30, 2025, mainly due to restructuring, impairments, and transformation costs.
Net finance expense for the nine months was $483 million, up from $440 million in 2024.
Outlook and guidance
Management expects sufficient liquidity for at least the next twelve months, supported by cash balances, future operating cash flow, and credit facilities.
Expect mid-single-digit constant currency growth in glass packaging adjusted EBITDA for full year 2025.
Projected net leverage at restricted group to be around 5.4x adjusted EBITDA at year-end 2025.
CapEx expected to be slightly below $300 million for 2025 and below that in 2026.
AMP upgraded full-year adjusted EBITDA guidance to $720–$735 million.
Latest events from Ardagh Group
- Adjusted EBITDA up 11%, leverage reduced, and liquidity improved after recapitalization.ARD
Q4 202526 Feb 2026 - Adjusted EBITDA up 13% in Q4 2024; 2025 targets mid-single-digit growth amid stable liquidity.ARD
Q4 202426 Dec 2025 - Revenue and EBITDA rose, but restructuring costs and debt maturities pose ongoing risks.ARD
Q1 202525 Nov 2025 - Recapitalization to cut $4.3B debt and add $1.5B capital amid mixed segment results.ARD
Q2 202516 Nov 2025 - Revenue and EBITDA declined year-over-year, with exceptional charges driving higher net losses.ARD
Q2 202428 Jul 2025 - Adjusted EBITDA rose 8% in Q3 2024, but net loss widened on significant restructuring costs.ARD
Q3 202428 Jul 2025